# Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

> **NCT02871518** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 236 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Cisplatin combine with IMRT
- **DRUG:** Cisplatin combine with IMRT

## Key facts

- **NCT ID:** NCT02871518
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-07
- **Final completion:** 2021-07
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02871518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02871518, "Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02871518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*